Neurotransmitters in disorders of consciousness and brain damage

Medical Hypotheses

Volumn 77, Issue 2, 2011, Pages 209-213

  Clauss, R P ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMANTADINE; APOMORPHINE; BACLOFEN; BROMOCRIPTINE; DOPAMINE; GLUTAMIC ACID; LACTIC ACID; LEVODOPA; METHYLPHENIDATE; NEUROTRANSMITTER; OXALOACETIC ACID; PROTRIPTYLINE; PYRUVIC ACID; SEROTONIN; TRICYCLIC ANTIDEPRESSANT AGENT; ZOLPIDEM;

ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN INJURY; CEREBRAL PALSY; COMA; COMATOSE PATIENT; CONSCIOUSNESS DISORDER; ELECTROSTIMULATION THERAPY; GENE EXPRESSION; HUMAN; HYPERBARIC OXYGEN; MINIMALY CONSCIOUS STATE; NERVE FIBER; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SUPPLY; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPASTICITY; SYNAPSE; THALAMOCORTICAL TRACT; THALAMUS; TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN INJURY;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; AXONS; BACLOFEN; CONSCIOUSNESS DISORDERS; DOPAMINE AGENTS; ELECTRIC STIMULATION; HUMANS; MODELS, BIOLOGICAL; NEUROTRANSMITTER AGENTS; OXYGEN; PYRIDINES; SYNAPSES;

EID: 79960631946     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.04.014     Document Type: Article

References (99)

1. Georgiopoulos M., Katsakiori P., Kefalopoulou Z., Ellu J., Chroni E., Constantoyannis C. Vegetative state and minimally conscious state: a review of the therapeutic interventions. Stereotact Func Neurosurg 2010, 88:199-207.
2. Oldendorf W.H. Brain uptake of radiolabelled amino acids, amines and hexoses after arterial injection. Am J Phys 1971, 221:1629-1639.
3. Hawkins R.A. The blood-brain barrier and glutamate. Am J Clin Nutr 2009, 90:867S-874S.
4. Newsholme P., Lima M.M., Procopio J., Pithon-Curi T.C., Doi S.Q., Bazotte R.B., et al. Glutamine and glutamate as vital metabolites. Braz J Med Biol Res 2003, 36:153-163.
5. Tapiero H., Mathé G., Couvreur P., Tew K.D. Glutamine and glutamate. Biomed Pharmacother 2002, 56:446-457.
6. Waagepetersen H.S., Qu H., Sonnewald U., Shimamoto K., Schoushoe A. Role of glutamine and neuronal glutamate uptake in glutamate homeostasis and synthesis during vesicular release in cultured glutamatergic neurons. Neurochem Int 2005, 47:92-102.
7. Siegel M. Why we sleep. Sci Am 2003, 291:92-97.
8. Cardinali D.P., Golombek D.A. The rhythmic GABAergic system. Neurochem Res 1998, 23:607-614.
9. Castaneda T.R., Marquez de Prado B., Prieto D., Mora F. Circadian rythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res 2004, 36:177-185.
10. Grimes M.A., Cameron J.L., Fernstrom J.D. Cerebrospinal fluid concentrations of large neutral and basic amino acids in Macca mulatta: diurnal variations and responses to chronic changes in dietary protein intake. Metabolism 2009, 58:129-140.
11. Marquez de Prado B., Castaneda T.R., Galindo A., DedArco A., Segovia G., Reiter R.J., et al. Melatonin disrupts circadian rythms of glutamate and GABA in the neostriatum of the awake rat: a microdialysis study. J Pineal Res 2000, 29:209-216.
12. Jennett B., Teasdale G. Aspects of coma after severe head injury. Lancet 1977, 8017:878-881.
13. Young G.B. Coma. Ann NY Acad Sci 2009, 1157:32-47.
14. Multi-society task force on PVS. Medical aspects of the persistent vegetative state- first of two parts. New Engl J Med 1994;330:1499-1508.
15. Giacino J.T., Ashwal S., Childs N., et al. The minimally conscious state: definition and diagnostic criteria. Neurology 2002, 58:349-353.
16. Clauss R.P., Nel H.W. Drug induced arousal from permanent vegetative state. Neuro Rehabil 2006, 21:23-28.
17. Chen H., Chan D.C. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 2009, 18(R2):R169-R176.
18. Goldstein A.Y., Wang X., Schwarz T.L. Axonal transport and the delivery of pre-synaptic components. Curr Opin Neurobiol 2008, 18(5):495-503.
19. Goldstein L.S.B., Yang Z.H. Microtubule- based transport systems in neurons: The roles of kinesins and dyneins. Annu Rev Neurosci 2000, 23:39-71.
20. Brown A. Axonal transport of membranous and non membranouscargoes: a unified perspective. J Cell Biol 2003, 160(6):817-821.
21. Breuer A.C., Atkinson M.B. Calcium dependent modulation of fast axonal transport. Cell Calcium 1988, 9(5-6):293-301.
22. Tymianski M., Tator C.H. Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 1996, 38(6):1176-1195.
23. LoPachim R.M., Lehning E.J. Mechanism of calcium entry during axon injury and degeneration. Toxicol Appl Pharmacol 1997, 143(2):233-244.
24. Wolf J.A., Stys P.K., Lusardi T., Meaney D., Smith D.H. Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci 2001, 21(6):1923-1930.
25. Kapoor R., Davies M., Blaker P.A., Hall S.M., Smith K.J. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 2003, 53(2):174-180.
26. De Vos K.J., Grierson A.J., Ackerley S., Miller C.C.J. Role of axonal transport in neurodegenerative diseases. Neuroscience 2008, 31:151-173.
27. Gentleman S.M., Roberts G.W., Gennarelli T.A., et al. Axonal injury: a universal consequence of fatal closed head injury?. Acta Neuropathol (Berl) 1995, 89:537-543.
28. Geddes J.F., Whitwell H.L., Graham D.I. Traumatic or diffuse axonal injury? Author's response. Neuropathol Appl Neurobiol 2000, 26:491.
29. Jane J.A., Steward O., Gennarelli T. Axonal degeneration induced by experimental noninvasive minor head injury. J Neurosurg 1985, 62:96-100.
30. Blumbergs P.C., Scott G., Manavis J., Wainwright H., Simpson D.A., McLean A.J. Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 1994, 344:1055-1056.
31. Adams J.H., Graham D.I., Jennett B. The neuropathology of the vegetative state after acute insult. Brain 2000, 123:1327-1338.
32. Kinney H.C., Samuels M.A. Neuropathology of the persistent vegetative state [Review]. J Neuropathol Exp Neurol 1994, 53:548-558.
33. Fitzpatrick M.O., Dewar D., Teasdale G.M., Graham D.I. The neuronal cytoskeleton in acute brain injury. Br J Neurosurg 1998, 12:313-317.
34. Masliah E., Terry R. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol 1993, 3:77-85.
35. Masliah E. Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 1995, 10(2):509-519.
36. Terry R.D., Masliah E., Salmon D.P., et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991, 30:572-580.
37. Hariri M., Hammerschlag R. Axonal transport of glutamic acid decarboxylase in crayfish peripheral nerve: dependence on contact between soma and axon. Neurosci Lett 1978, 7(4):319-325.
38. Bak L.K., Schousboe A., Waagepeterson H.S. The glutamate/GABA- glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 2006, 98:641-653.
39. Grafstein B. Subverting the hegemony of the synapse: complicity of neurons, astrocytes, and vasculature in spreading depression and pathology of the cerebral cortex. Brain Res Rev 2011, 66(1-2):123-132.
40. Kline D.D., Hendricks G., Hermann G., Rogers R.C., Kunze D.L. Dopamine inhibits N-type channels in visceral afferents to reduce synaptic transmitter release under normoxic and chronic intermittent hypoxic conditions. J Neurophysiol 2009, 101(5):2270-2278.
41. Tekkök S.B., Ransom B.R. Anoxia effects on CNS function and survival: regional differences. Neurochem Res 2004, 29(11):2163-2169.
42. Nieuwenhuys R. The neocortex. An overview of its evolutionary development, structural organization and synaptology. Anat Embryol (Berl) 1994, 190(4):307-337.
43. Kumar A., Cook I.A. White matter injury, neural connectivity and the pathophysiology of psychiatric disorders. Dev Neurosci 2002, 24(4):255-261.
44. Taber K.H., Hurley R.A. Traumatic axonal injury: atlas of major pathways. J Neuropsych Clin Neurosci 2007, 19:4-104.
45. Brown E.N., Lydic R., Schiff N.D. General anesthesia, sleep and coma. N Engl J Med 2010, 363:2638-2650.
46. Jones B.E. Arousal systems. Frontiers Biosci 2003, 8:438-451.
47. Rodriguez A., Whitson J., Granger R. Derivation and analysis of basic computational operations of thalamocortical circuits. J Cogn Neurosci 2004, 16(5):856-877.
48. Greiceus M.D., Krasnow B., Menon V., Reiss A.L. Functional connectivity in the resting brain: A network analysis of the default mode hypothesis. PNAS 2003, 100:253-258.
49. Silva S., Alacoque X., Fourcade O., et al. Wakefulness and loss of awareness: brain and brainstem interaction an the vegetative state. Neurology 2010, 74(4):313-320.
50. Machado C., Leisman G. Towards an effective definition of death and disorders of consciousness. Rev Neurosci 2009, 20(3-4):147-150.
51. Anju T.R., Peeyush Kumar T., Paulose C.S. Decreased GABAA receptors functional regulation in the cerebral cortex and brainstem of hypoxic neonatal rats: effect of glucose and oxygen supplementation. Cell Mol Neurobiol 2010, 30(4):599-606.
52. Goddard A.W., Ball S.G., Martinez J., et al. Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety 2010, 27(4):339-350.
53. Fernstrom J.D. Branched-chain amino acids and brain function. J Nutr 2005, 135:1539S-1546S.
54. Nilsson G.E., Alfaro A.A., Lutz P.L. Changes in turtle brain neurotransmitters and related substances during anoxia. Am J Physiol Regul Integr Comp Physiol 1990, 259:R376-R384.
55. Sarrafzadeh A.S., Kiening K.L., Callsen T.A., Unterberg A.W. Metabolic changes during impending and manifest cerebral hypoxia in traumatic brain injury. Br J Neurosurg 2003, 17:340-346.
56. Reinert M., Hoelper B., Doppenberg E., Zauner A., Bullock R. Substrate delivery and ionic balance disturbance after severe human head injury. Acta Neurochir Suppl. 2000, 76:439-444.
57. Clark J.F., Doepke A., Filosa J.A., et al. N-acetylaspartate as a reservoir for glutamate. Med Hypotheses 2006, 67:506-512.
58. Erecińska M., Pleasure D., Nelson D., Nissim I., Yudkoff M. Cerebral aspartate utilization: near-equilibrium relationships in aspartate aminotransferase reaction. J Neurochem 1993, 60:1696-1706.
59. Higuchi T., Fernandez E.J., Maudsley A.A., Shimizu H., Weiner M.W., Weinstein P.R. Mapping of lactate and N-acetyl-L-aspartate predicts infarction during acute focal ischemia: in vivo 1H magnetic resinance spectroscopy in rats. Neurosurgery 1996, 38:121-129.
60. Lee D.H., Kang D.-W., Ahn J.S., Choi C.G., Kim S.J., Suh D.C. Imaging of the ischemic penumbra in acute stroke. Korean J Radiol 2005, 6:64-74.
61. Brinton R.D., Thompson R.F., Foy M.R., et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol 2008, 29:313-339.
62. Biggio F., Gorini G., Caria S., et al. Plastic neuronal changes in GABA (A) receptor gene expression induced by progesterone metabolites: in vitro molecular and functional studies. Pharmacol Biochem Behav 2006, 84(4):545-554.
63. Clauss R.P., Güldenpfennig W.M., Nel H.W., Sathekge M.M., Venkannagari R.R. Extraordinary arousal from the semi-comatose state on zolpidem. A case report. S Afr Med J 2000, 90(1):68-72.
64. Nyakale N.E., Clauss R.P., Nel H.W., Sathekge M.M. Clinical and Brain SPECT scan response to zolpidem in patients after brain damage. Arzneimittel Forschung Drug Res 2010, 60:177-181.
65. Clauss R.P., Nel H.W. The effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO Brain SPECT in humans. Arzneim.-Forsch./Drug Res 2004, 54:641-646.
66. Salva P., Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet 1995, 29:142-153.
67. Cohen L., Chaaban B., Haberl M.O. Transient improvement of aphasia with zolpidem. N Engl J Med 2004, 350:949-950.
68. Brefel-Courbon C., Payoux P., Ory F., et al. Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. Ann Neurol 2007, 62:102.
69. Hall S.D., Yamawaki N., Fisher A.E., Clauss R.P., Woodhall G.L., Stanford I.M. GABA (A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke - a case report. Clin Neurophysiol 2010, 121(4):549-555.
70. Du B., Shan A., Yang D., Xiang W. Induced arousal following zolpidem treatment in a vegetative state after brain injury in seven cases: analysis using visual single photon emission conputerized tomography and digitized cerebral state monitor. Neurl Regeneration Res 2008, 3/1(94096):1673-5374.
71. Whyte J., Myers R. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. Am J Phys Med Rehabil 2009, 88:410-418.
72. Sará M., Pistoia F., Mura E., Onorati P., Govoni S. Intrathecal baclofen in patients with persistent vegetative state: 2 hypothesis. Arch Phys Med Rehabil 2009, 90:1245-1249.
73. Taira T. Intrathecal administration of GABA agonists in the vegetative state. Prog Brain Res 2009, 117:317-328.
74. Nockels R., Young W. Pharmacologic strategies in the treatment of experimental spinal chord injury. J Neurotrauma 1992, 9(1):S211-S217.
75. Matsuda W., Komatsu Y., Yanaka K., Matsumura A. Levodopa treatment for patients in persistent vegetative or minimally conscious status. Neuropsychol Rehábil 2005, 15:414-427.
76. Passler M.A., Riggs R.V. Positive outcomes in traumatic brain injury-vegetative state: patients treated with bromocriptine. Arch Phys Med Rehabil 2001, 82:311-315.
77. Fridman E.A., Calvar J., Bonetto M., et al. Fast awakening from Minimally Conscious State with apomorphine. Brain Inj 2009, 23:172-177.
78. Zafonte R.D., Watanabe T., Mann N.R. Amantidine: a potential treatment for the minimally conscious state. Brain Inj 1998, 12:617-621.
79. Whyte J., Hart T., Vaccaro M., et al. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil 2004, 83:401-420.
80. Reinhard D.L., Whyte J., Sandel M.E. Improved arousal and initiation following tricyclic antidepressant use in severe brain injury. Arch Phys Med Rehabil 1997, 78:109.
81. Wroblewski B., Glenn M.B., Cornblatt R., Joseph A.B., Suduikis S. Protriptyline as an alternative stimulant medication in patients with brain injury: a series of case reports. Brain Inj 1993, 7:353-362.
82. Cornblatt F., Richer E. Deep cerebral stimulation in patients with post traumatic vegetative state: 25 cases. Neurochirurgie 1993, 39:281-292.
83. Canavero S., Massa-Micon B., Cauda F., Montanaro E. Bifocal extradural cortical stimulation-induced recovery of consciousness in the permanent post traumatic vegetative state. J Neurol 2009, 256:834-836.
84. Morita I., Keith M.W., Kanno T. Dorsal column stimulation in the persistent vegetative state. Acta Neurochir Suppl 2007, 97(Pt 1):455-459.
85. Cooper E.B., Scherder E.J., Cooper J.B. Electrical treatment of reduced consciousness: experience with coma and Alzheimer's disease. Neuropsychol Rehabil 2005, 15:389-405.
86. Pape T., Rosenow J., Lewis G., et al. Repetitive transcranial magnetic stimulation- associated neurobehavioural gains during coma recovery. Brain Stimul 2009, 2(1):22-35.
87. Tsubokawa T., Yamamoto T., Katayama Y., Hirayama T., Maejima S., Moriya T. Deep-brain stimulation in a persistant vegetative state: follow- up results and criteria for selection of candidates. Brain Inj 1990, 4:315-327.
88. Schiff N.D., Giacino J.T., Kalmar K., et al. Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature 2007, 448:600-603.
89. Van Grompel J.J., Chang S.Y., Goerss S.J., et al. Development of intraoperative electrochemical detection: wireless instantaneous neurochemical concentration sensor for deep brain stimulation feedback. Neurosurg Focus 2010, 29(2):E6.
90. Sesia T., Bulthuis V., Tan S., et al. Deep brain stimulation of the nucleus accumbens shell increases impulsive behaviour and tissue levels of dopamine and serotonin. Exp Neurol 2010, 225(2):302-309.
91. Kanno T., Kamel Y., Yokoyama T., Shoda M., Tanji H., Nomura M. Effects of dorsal column spinal chord stimulation (DCS) on reversibility of neuronal function- experience of treatment for vegetative states. Pacing Clin Electrophysiol 1989, 12(4 Pt 2):733-738.
92. Cooper J.B., Jane J.A., Alves W.M., Cooper E.B. Right median nerve stimulation to hasten awaking from coma. Brain Inj 1999, 13(4):261-267.
93. Liu J.T., Wang C.H., Chou I.C., Sun S.S., Koa C.H., Cooper E. Regaining consciousness for prolonged comatose patients with right median nerve stimulation. Acta Neurochir Suppl 2003, 87:11-14.
94. Collet J.P., Vanasse M., Marois P., et al. Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. HBO-CP research group. Lancet 2001, 357(9256):582-586.
95. Xie K., Wang P. Clinical study on the effect of HBO plus electric stimulation on treatment for the vegetative state. Acta Neurochirg Suppl 2003, 87:19-21.
96. Yamamoto H. Hyperammonemia. Increased brain neutral and aromatic amino acid levels, and encephalopathy induced by cyanide in mice. Toxicol Appl Pharmacol 1989, 99(3):415-420.
97. Hariharakrishnan J., Satpute R., Bhattacharya R. Cyanide induced changes in the levels of neurotransmitters in discrete brain regions of rats and their response to oral treatment with alpha- ketogluterate. Indian J Exp Biol 2010, 48(7):731-736.
98. Campos F., Sobrino T., Ramos-Cabrer P., Argibay B., Agulla J., Perez-Mato M., et al. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J Cereb Blood F Met 2011, 3:1-9.
99. Voss H.U., Uluc A.M., Dyke J.P., et al. Possible axonal regrowth in late recovery from the minimally conscious state. J Clin Invest 2006, 116:2005-2011.